Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special Reports
Top 10 pharma R&D budgets of 2025
All of the companies on this year's list also made last year's ranking, but most of them made substantial cuts to their R&D spending.
Darren Incorvaia
Mar 30, 2026 3:00am
Lilly embraces AI biotech Insilico again, inking $2.75B collab
Mar 29, 2026 8:00pm
Scaling Radioligand Therapy: Expanding the Impact of Theranostics
Brought to you by
Curium
Biogen’s litifilimab sparkles in midphase lupus trial
Mar 30, 2026 4:45am
Kailera plots IPO to fund Hengrui-licensed obesity pipeline
Mar 30, 2026 3:45am
Astellas axes early trial for Sjögren’s syndrome
Mar 30, 2026 2:18pm
More News
Blackstone closes record $6.3B life sciences fund
Mar 30, 2026 1:50pm
Merck dives into data showing PCSK9 pill easily outswims rivals
Mar 30, 2026 11:45am
Boston Scientific heart plug stands up to blood thinners at ACC
Mar 30, 2026 11:02am
Kevin Tang uses control of Aurinia to finally take over Kezar
Mar 30, 2026 10:53am
See more stories